Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 69 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 8513302

    Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids

    The Regents of the University of California · Granted Aug 20, 2013 · Expires Aug 15, 2033

    granted

  2. US 8507522

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  3. US 8507672

    Substituted pyrrolo[2,3-d]pyrimidines as LIM kinase 2 inhibitors

    LEXICON PHARMACEUTICALS, INC. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted

  4. US 8501682

    Difluorinated tripeptides as HCV serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  5. US 8501681

    Macrocyclic hepatitis C virus serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  6. US 8501783

    Conformationally restricted urea inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  7. US 8501740

    Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors

    The Board of Regents of the University of Texas System · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  8. US 8501446

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  9. US 8501964

    Serotonin reuptake inhibitors

    Theravance, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  10. US 8497307

    Aryl guanidine F1F0-ATPase inhibitors and related methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  11. US 8492428

    Small-molecule botulinum toxin inhibitors

    The United States of America as represented by the Secretary of the Army · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  12. US 8492373

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  13. US 8486989

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  14. US 8481044

    Neprilysin inhibitors

    Theravance, Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  15. US 8481551

    Gyrase and topoisomerase IV inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  16. US 8481538

    Heterocyclic inhibitors of c-Met and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  17. US 8481599

    Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism

    TONIX PHARMACEUTICALS HOLDING CORP · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  18. US 8481578

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  19. US 8481524

    c-MET protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  20. US 8476043

    Inhibitors for the soluble epoxide hydrolase

    The Regents of the University of California · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  21. US 8471040

    Serotonin reuptake inhibitors

    Theravance, Inc. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  22. US 8471014

    Process of making gyrase and topoisomerase IV inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  23. US 8470837

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  24. US 8466288

    Isoindolinone inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.